Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tremelimumab
Pharma
BMS, AZ settle cancer immunotherapy patent suits for $510M
AstraZeneca has agreed to pay $510 million to resolve all patent disputes with Bristol Myers Squibb and Ono Pharmaceutical.
Angus Liu
Aug 1, 2023 10:09am
BMS claims AstraZeneca's Imjudo violates two Yervoy patents
Jan 24, 2023 4:13pm
AZ's Imjudo faces more fierce competition after new cancer nod
Nov 11, 2022 10:00am
'The Top Line': Biogen's earnings call, AstraZeneca's CTLA-4 nod
Oct 28, 2022 6:00am
AstraZeneca's CTLA-4 drug treme finally snags its first approval
Oct 24, 2022 10:48am
FDA accepts AZ's application for tremelimumab in liver cancer
Apr 25, 2022 9:29am